What is the National Breast Cancer Research Framework?

The National Breast Cancer Research Framework is the product of a broad-based, comprehensive and collaborative process. It reflects the input of funders, breast cancer survivors, researchers and clinicians from across the country and, looking ahead, offers a coherent vision of the most promising areas for breast cancer research.

The Framework is essentially a Roadmap for Research. It identifies existing and emerging research priorities, encourages collaboration among funders and articulates a call to action aimed at all members of the Canadian breast cancer community.

Background & Development

Background & Development

Members of the Canadian Breast Cancer Research Alliance (Avon Foundation for Women – Canada, Canadian Breast Cancer Foundation, Canadian Breast Cancer Network, Canadian Cancer Society, Canadian Institutes of Health Research, Health Canada and the Public Health Agency of Canada) determined the need to capitalize on the growth of Canadian research talent, the widening interest in strategic research investment and the burgeoning knowledge about breast cancer to undertake an inclusive process to develop a national breast cancer research strategic framework that would guide all funders of breast cancer research in Canada.

The development of this Framework was the result of extensive discussions involving funders, breast cancer patients and survivors, and researchers from across Canada and internationally.

The opportunity is clear: to identify existing and emerging research priorities, areas that maximize Canada’s comparative advantages and represent the best fit of Canadian initiatives within a larger set of provincial/territorial, regional, national and international initiatives, and to articulate a call to action.

The National Framework builds on foundational elements already in place. The goal is to harness the existing momentum to increase levels of research impact while using resources more effectively. By articulating what is most important, the National Framework challenges the breast cancer community to step forward and act on these agreed priorities.

<!–:en–>Who Is Involved?<!–:–><!–:fr–>Qui participe?<!–:–>

Who is Involved?

The following organizations supported the development of the National Breast Cancer Research Framework:

Many individuals were involved in developing the National Breast Cancer Research Framework.

Part One: National Summit Working Group Members

  • Dr. Phil Branton (Co-Chair), CIHR
  • Dr. Moira Stilwell (Co-Chair), CBCF
  • Dr. Elizabeth Eisenhauer, NCIC/CCS
  • Diana Ermel, CBCN
  • Heidi Liepold, PHAC
  • Dr. Ivo Olivotto, CBCRA Research Advisory Committee Chair
  • Dr. Morag Park, Researcher
  • Dr. Cathy Popadiuk, CBCRA Board Member-at-Large
  • Nicky Lewis, CBCRA Executive Director
  • Dr. Jane Cooke-Lauder, Bataleur Enterprises Inc. (consultant)

Part Two: National Framework Working Group Members

Dr. Eva Grunfeld
(Co-Chair)
Director, Knowledge Translation Research, Health Services Research Program
Cancer Care Ontario and the Ontario Institute for Cancer Research
Toronto, Ontario
Dr. Morag Park
(Co-Chair)
Scientific Director, CIHR Institute of Cancer Research
Member, CBCRA Board of Directors
Québec, Québec
Dr. Heather Bryant
Vice-President, Cancer Control, Canadian Partnership Against Cancer
Toronto, Ontario
Dr. Mario Chevrette
President, The Cancer Research Society
Montréal, Québec
Dr. Elizabeth Eisenhauer
Co-Chair, Canadian Cancer Research Alliance
Chair, Canadian Partnership Against Cancer Research Action Group
Member, CBCRA Board of Directors
Kingston, Ontario
Dr. Margaret Fitch
Head, Oncology Nursing, Sunnybrook Research Institute
Toronto, Ontario
Dr. Christine Friedenreich
Research Scientist, Division of Population Health and Information,
Tom Baker Cancer Centre
Calgary, Alberta
Dr. Karen Gelmon
Head Investigational Drug Program, Advanced Therapeutics,
Dept. of Medical Oncology, BC Cancer Agency
Vancouver, British Columbia
Dr. Thomas Hack
Associate Professor, Faculties of Medicine, Nursing, and Graduate Studies, University of Manitoba
Clinical Psychologist, CancerCare Manitoba
Member, CBCRA Research Advisory Committee
Winnipeg, Manitoba
Dr. Claire Holloway
Associate Scientist and Surgical Oncologist,
Sunnybrook Health Sciences Centre
Chair, CBCRA Research Advisory Committee
Toronto, Ontario
Dr. Tom Hudson
President and Scientific Director, Ontario Institute for Cancer Research
Toronto, Ontario
Dr. Victor Ling
Scientific Director, Terry Fox Research Institute
Vancouver, British Columbia
Dr. Sylvie Mader
Professor, Institute for Research in Immunology and Cancer, University of Montréal
Member, CBCRA Research Advisory Committee
Montréal, Québec
Dr. Michael Pollak
Director, Cancer Prevention Centre, Segal Cancer Centre
Professor, Department of Oncology, McGill University
Montréal, Québec
Dr. Jim Woodgett
Director of Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Member, CBCRA Research Advisory Committee
Toronto, Ontario
Dr. Martin Yaffe
Senior Scientist, Sunnybrook Health Sciences Centre
Member, CBCRA Research Advisory Committee
Toronto, Ontario
Stewardship & CBCRA

Stewardship & CBCRA

The Canadian Breast Cancer Research Alliance is committed to leading the implementation of the National Framework.

CBCRA will encourage adoption of all the Framework’s priorities and recommendations by all breast cancer research funders in Canada. In pursuit of this goal, CBCRA will apply a range of strategies including hosting forums to maintain interaction among funders and using its pooled research funds to attract other funders, working with them to find common interests and developing new structures and funding mechanisms.

CBCRA will ensure that the National Framework document is kept current. Emerging trends and activities in the cancer and health research environments will be tracked. Trends in breast cancer research funding will be reported with assistance from CCRA/CPAC. CBCRA will host forums with groups of experts – possibly by priority or by theme – to ensure that new knowledge is shared and introduced into the National Framework document. The implications of all the data will be reviewed by a committee of national and international experts for its impact on the research priorities. Updates will be published featuring progress reports and success stories. CBCRA will also publish and promote opportunities to increase efficiencies in the funding, management and delivery of world-class breast cancer research.

Get Involved /?page_id=14'>Get Involved Get Involved